CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C01504 | BRD-A63289646 | endosulfan | -- | -- | -- | Details |
| C01505 | BRD-A63310107 | miglitol | GAA; MGAM | Glucosidase inhibitor | -- | Details |
| C01506 | BRD-A63342325 | BRD-A63342325 | -- | -- | -- | Details |
| C01507 | BRD-A63346720 | rimcazole | SIGMAR1 | Sigma receptor antagonist | -- | Details |
| C01508 | BRD-A63382799 | BRD-A63382799 | -- | -- | -- | Details |
| C01509 | BRD-A63444178 | ME-0328 | -- | -- | -- | Details |
| C01510 | BRD-A63445921 | nicardipine | CACNA1C | Calcium channel blocker | -- | Details |
| C01511 | BRD-A63501481 | BRD-A63501481 | -- | -- | -- | Details |
| C01512 | BRD-A63503250 | BRD-A63503250 | -- | -- | N-[3-(4-chlorophenyl)-4-methyl-3H-1,5-benzodiazepin-2-yl]benzamide | Details |
| C01513 | BRD-A63546914 | Ro-04-5595 | GRIN2B | Glutamate receptor antagonist | -- | Details |
| C01514 | BRD-A63583287 | SA-1447005 | -- | -- | -- | Details |
| C01515 | BRD-A63590986 | BRD-A63590986 | -- | -- | -- | Details |
| C01516 | BRD-A63610676 | paclitaxel | TUBB; NR1I2 | Tubulin inhibitor | -- | Details |
| C01517 | BRD-A63646118 | fumonisin-b1 | CERS1 | Sphingosine N acyltransferase inhibitor | FUMONISIN-B1 | Details |
| C01518 | BRD-A63667919 | BRD-A63667919 | -- | -- | methylergometrine | Details |
| C01519 | BRD-A63675168 | brivudine | -- | -- | -- | Details |
| C01520 | BRD-A63704386 | BRD-A63704386 | -- | -- | -- | Details |
| C01521 | BRD-A63752151 | fidarestat | AKR1B1 | Aldose reductase inhibitor | -- | Details |
| C01522 | BRD-A63759745 | BRD-A63759745 | -- | -- | -- | Details |
| C01523 | BRD-A63780829 | hyperin | AKR1B1 | Aldose reductase inhibitor | -- | Details |
| C01524 | BRD-A63836183 | PD-123319 | AGTR2 | Angiotensin antagonist | -- | Details |
| C01525 | BRD-A63894585 | clobetasol | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C01526 | BRD-A63934767 | alclometasone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
| C01527 | BRD-A63949900 | BRD-A63949900 | -- | -- | -- | Details |
| C01528 | BRD-A63951967 | DS-437 | -- | -- | -- | Details |
| C01529 | BRD-A63989068 | apicidin | HDAC6; HDAC5; HDAC1; HDAC2; HDAC7; HDAC8; HDAC11; HDAC10; HDAC3; HDAC9; HDAC4 | HDAC inhibitor | -- | Details |
| C01530 | BRD-A63998256 | helveticoside | -- | -- | -- | Details |
| C01531 | BRD-A64091909 | BRD-A64091909 | -- | -- | -- | Details |
| C01532 | BRD-A64092382 | mexiletine | SCN5A | Sodium channel blocker | -- | Details |
| C01533 | BRD-A64125466 | dehydrocholate | -- | -- | -- | Details |
| C01534 | BRD-A64153357 | BRD-A64153357 | -- | -- | -- | Details |
| C01535 | BRD-A64227845 | SKF-77434 | DRD1 | Dopamine receptor agonist | -- | Details |
| C01536 | BRD-A64228451 | terreic-acid | -- | -- | terreic-acid-(-) | Details |
| C01537 | BRD-A64237946 | BRD-A64237946 | -- | -- | -- | Details |
| C01538 | BRD-A64242993 | lanatoside-c | -- | -- | -- | Details |
| C01539 | BRD-A64290322 | cyclosporin-a | PPIA; PPP3CA | Calcineurin inhibitor | -- | Details |
| C01540 | BRD-A64297288 | amlodipine | CACNA1C; CACNA1D; CACNA1S; CACNA2D1 | Calcium channel blocker | -- | Details |
| C01541 | BRD-A64374397 | BRD-A64374397 | -- | -- | -- | Details |
| C01542 | BRD-A64406146 | timofibrate | LPL | Cholesterol inhibitor; Lipase clearing factor inhibitor | -- | Details |
| C01543 | BRD-A64479082 | quinidine | SCN5A | Sodium channel blocker | -- | Details |
| C01544 | BRD-A64485570 | trifluridine | TYMS | Thymidylate synthase inhibitor; DNA directed DNA polymerase inhibitor | -- | Details |
| C01545 | BRD-A64489120 | 6-nitronorepinephrine | -- | -- | 6-NITRONOREPINEPHRINE | Details |
| C01546 | BRD-A64523751 | BRD-A64523751 | -- | -- | -- | Details |
| C01547 | BRD-A64553394 | DPI-201106 | -- | -- | -- | Details |
| C01548 | BRD-A64610707 | pranoprofen | -- | -- | -- | Details |
| C01549 | BRD-A64761364 | BRD-A64761364 | -- | -- | -- | Details |
| C01550 | BRD-A64774838 | BRD-A64774838 | -- | -- | -- | Details |
| C01551 | BRD-A64808605 | AH-11110 | -- | -- | -- | Details |
| C01552 | BRD-A64811980 | NK42-I-109-1 | -- | -- | -- | Details |
| C01553 | BRD-A64849281 | BRD-A64849281 | -- | -- | -- | Details |
| C01554 | BRD-A64850503 | BRD-A64850503 | -- | -- | -- | Details |
| C01555 | BRD-A64915300 | BRD-A64915300 | -- | -- | -- | Details |
| C01556 | BRD-A64933752 | CV-1808 | ADORA2A | Adenosine receptor agonist | -- | Details |
| C01557 | BRD-A64957606 | BRD-A64957606 | -- | -- | -- | Details |
| C01558 | BRD-A64977602 | mirtazapine | ADRA2A; ADRA2B; ADRA2C; HTR2A; HTR2C; HTR3A | Serotonin receptor antagonist; Adrenergic receptor antagonist | -- | Details |
| C01559 | BRD-A64985224 | BRD-A64985224 | -- | -- | -- | Details |
| C01560 | BRD-A65013509 | oxybutynin | CHRM1; CHRM2; CHRM3 | Acetylcholine receptor antagonist | -- | Details |
| C01561 | BRD-A65051990 | acenocoumarol | VKORC1 | Vitamin K antagonist | -- | Details |
| C01562 | BRD-A65076780 | BRD-A65076780 | -- | -- | dihydroergocristine | Details |
| C01563 | BRD-A65140285 | BRD-A65140285 | -- | -- | -- | Details |
| C01564 | BRD-A65142661 | BRD-A65142661 | -- | -- | -- | Details |
| C01565 | BRD-A65145453 | ATPA | GRIK1 | Glutamate receptor agonist | atpa | Details |
| C01566 | BRD-A65149943 | BRD-A65149943 | -- | -- | -- | Details |
| C01567 | BRD-A65248799 | EMD-53998 | -- | -- | -- | Details |
| C01568 | BRD-A65280694 | molindone | DRD2; HTR2A | Dopamine receptor antagonist | -- | Details |
| C01569 | BRD-A65282128 | cefazolin | -- | -- | -- | Details |
| C01570 | BRD-A65327625 | 6-hydroxytropinone | -- | -- | 6-HYDROXYTROPINONE | Details |
| C01571 | BRD-A65440446 | cimaterol | ADRB1; ADRB2; ADRB3 | Adrenergic receptor agonist | -- | Details |
| C01572 | BRD-A65444648 | imidazolidinyl-urea | -- | -- | -- | Details |
| C01573 | BRD-A65449987 | flunisolide | NR3C1 | Cytochrome P450 inhibitor | -- | Details |
| C01574 | BRD-A65516924 | BRD-A65516924 | -- | -- | -- | Details |
| C01575 | BRD-A65550283 | ginsenoside | -- | -- | -- | Details |
| C01576 | BRD-A65592966 | BRD-A65592966 | -- | -- | -- | Details |
| C01577 | BRD-A65597028 | RX-821002 | ADRA2A; ADRA2B; ADRA2C | Adrenergic receptor antagonist | -- | Details |
| C01578 | BRD-A65615053 | zacopride | HTR3A; HTR4 | Serotonin receptor antagonist | -- | Details |
| C01579 | BRD-A65644766 | BAY-598 | -- | -- | -- | Details |
| C01580 | BRD-A65671304 | candesartan-cilextil | AGTR1 | Angiotensin receptor antagonist | -- | Details |
| C01581 | BRD-A65730376 | BRD-A65730376 | -- | -- | -- | Details |
| C01582 | BRD-A65739223 | ramipril | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
| C01583 | BRD-A65767837 | hydrocortisone-acetate | NR3C1 | Corticosteroid agonist; Glucocorticoid receptor agonist | -- | Details |
| C01584 | BRD-A65771317 | BRD-A65771317 | -- | -- | nor-2-chlorpromazine | Details |
| C01585 | BRD-A65797496 | deptropine | HRH1 | Histamine receptor antagonist | -- | Details |
| C01586 | BRD-A65806553 | BRD-A65806553 | -- | -- | -- | Details |
| C01587 | BRD-A65818372 | ioversol | -- | -- | -- | Details |
| C01588 | BRD-A66025870 | BRD-A66025870 | -- | -- | phenethicillin | Details |
| C01589 | BRD-A66116161 | AM-1241 | CNR2 | Cannabinoid receptor agonist | -- | Details |
| C01590 | BRD-A66155091 | trilostane | ESR1; ESR2; HSD3B2 | 3beta-hydroxy-delta5-steroid dehydrogenase inhibitor | -- | Details |
| C01591 | BRD-A66164310 | BRD-A66164310 | -- | -- | -- | Details |
| C01592 | BRD-A66165463 | BRD-A66165463 | -- | -- | -- | Details |
| C01593 | BRD-A66199457 | asiaticoside | -- | -- | -- | Details |
| C01594 | BRD-A66229260 | calcitriol | VDR | Vitamin D receptor agonist | -- | Details |
| C01595 | BRD-A66284731 | fenipentol | -- | -- | -- | Details |
| C01596 | BRD-A66369147 | BRD-A66369147 | -- | -- | -- | Details |
| C01597 | BRD-A66395008 | parthenolide | -- | -- | -- | Details |
| C01598 | BRD-A66419424 | MLN-9708 | -- | -- | ixazomib-citrate | Details |
| C01599 | BRD-A66435872 | HTMT | -- | -- | htmt | Details |
| C01600 | BRD-A66559694 | naltrexone | OPRD1; OPRK1; OPRM1 | Opioid receptor antagonist | -- | Details |
| C01601 | BRD-A66563878 | medetomidine | ADRA2A; ADRA2B; ADRA2C | Adrenergic receptor agonist | -- | Details |
| C01602 | BRD-A66566298 | BRD-A66566298 | -- | -- | -- | Details |
| C01603 | BRD-A66604020 | BRD-A66604020 | -- | -- | -- | Details |